Evidence map›Paper›PMID 27213625›Full record

ArticleAlzheimer disease and associated disorders

The Effectiveness of Small-group Community-based Information Sessions on Clinical Trial Recruitment for Secondary Prevention of Alzheimer's Disease.

Sarah D Tarrant, Shoshana H Bardach, Kendra Bates, Heather Nichols, Jacqueline Towner, Clay Tamatha, Allison Caban-Holt, Linda J Van-Eldik, Richard R Murphy, Reisa Sperling and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in Alzheimer disease and associated disorders. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02008357 (Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02008357 phase3completednot on this map

Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)

TypeinterventionalSponsorEli Lilly and CompanyRan2014 to 2023Enrolled1,169ConditionsCognition DisordersArmsPlacebo, Solanezumab
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Recruiting the Oldest-old for Clinical Research.Alzheimer disease and associated disorders
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sarah D Tarrant*University of Kentucky Alzheimer Disease Center †Sanders-Brown Center on Aging Departments of ‡Gerontology §Behavioral Science ∥Anatomy and Neurobiology ¶Neurology, University of Kentucky Colleges of Medicine & Public Health, Lexington, KY #Massachusetts Alzheimer Disease Research Center **Department of Neurology, Harvard Medical School, Boston, MA.
Shoshana H Bardach
Kendra Bates
Heather Nichols
Jacqueline Towner
Clay Tamatha
Allison Caban-Holt
Linda J Van-Eldik
Richard R Murphy
Reisa Sperling
Gregory A Jicha

Funding

TRIAL OF VALPROATE TO ATTENUATE THE PROGRESSION OF ADU01AG010483 · NIA · UNIVERSITY OF ROCHESTER · PI AISEN, PAUL S. · 1991 to 2012
$116.2M
RECRUITMENT COREU19AG010483 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FELDMAN, HOWARD · 2013 to 2020
$80.6M
University of Kentucky Alzheimer's Disease Core Center - Biomarker CoreP30AG028383 · NIA · UNIVERSITY OF KENTUCKY · PI GOLD, BRIAN TIMOTHY, VAN ELDIK, LINDA J · 2006 to 2020
$23.3M
NIA NIH HHS P30 AG028383NIA NIH HHS U01 AG010483NIA NIH HHS U19 AG010483
6 · The paper itself

Abstract

Effective and practical recruitment strategies are needed to ensure successful recruitment into the Alzheimer disease clinical trials. To facilitate successful recruitment for the NIH-sponsored A4 (Anti-Amyloid treatment in Asymptomatic Alzheimer's disease, NCT02008357) trial for the secondary prevention of Alzheimer disease, we developed a small-group community information session to attract and recruit potential research participants. After a successful media campaign, 213 participants were screened through telephone for eligibility, identifying 127 potential participants. Participants were given the option of a traditional one-on-one recruitment session or a small-group session. One-on-one recruitment was performed for 15 participants requesting this procedure, and yielded an overall recruitment rate of 67% (n=10). Substantially more individuals (n=112, 88%) requested small-group sessions to learn about the study. After attending the small-group informational sessions, 98% of potential participants self-reported a greater understanding of the study; and the recruitment rate from these sessions was 90%. Small-group sessions not only improved recruitment success rates, but also contributed to significantly shorter median time for consent processes (20 vs. 60 min) and reduced staff time spent on persons not recruited. Small-group education programs are an effective strategy for enhancing recruitment success and facilitating practical recruitment into clinical trials with high recruitment demands.

Indexed as

Clinical Trials as TopicPatient SelectionSecondary PreventionAgedAlzheimer DiseaseCommunity-Based Participatory ResearchFemaleHumansTelephone

Identifiers

PMID27213625
PMCPMC5116426

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.